MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT - PubMed (original) (raw)
Comparative Study
MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT
D W Paty et al. Neurology. 1988 Feb.
Abstract
We compared the diagnostic capabilities of MRI to CT, evoked potentials (EP), and CSF oligoclonal banding analysis in a prospective evaluation of 200 patients with suspected multiple sclerosis (MS). MRI was the best method for demonstrating dissemination in space. An abnormal appropriate EP in monosymptomatic disease was usually supported by MRI and CSF analysis as being predictive of MS as a clinical diagnosis. A normal appropriate EP study was not satisfactory because MRI and CSF analysis often did not support a diagnosis of non-MS. When there is agreement between three of these paraclinical studies, the diagnosis of MS is probably unequivocal. For use in research studies, laboratory-supported definite MS (LSDMS) could be diagnosed in 85 patients of the total 200 (42.5%), in 19/38 (50%) of optic neuritis (ON) patients, and in 24/52 (46%) of chronic progressive myelopathy (CPM) patients. MRI was 100% successful in identifying patients who qualified for LSDMS in the ON and CPM groups. In a short follow-up (less than 1 year), 19/200 (10%) went on to develop clinically definite MS (CDMS), and MRI predicted that diagnosis in 18/19 (95%). Only long-term follow-up will show how well these studies and the category of LSDMS predict the development of CDMS. The clinical diagnosis of MS (CDMS), even though only 95% accurate, must remain the gold standard.
Similar articles
- Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.
Lee KH, Hashimoto SA, Hooge JP, Kastrukoff LF, Oger JJ, Li DK, Paty DW. Lee KH, et al. Neurology. 1991 May;41(5):657-60. doi: 10.1212/wnl.41.5.657. Neurology. 1991. PMID: 2027480 - Comparative impact of paraclinical studies in establishing the diagnosis of multiple sclerosis.
Gilmore RL, Kasarskis EJ, Carr WA, Norvell E. Gilmore RL, et al. Electroencephalogr Clin Neurophysiol. 1989 Nov;73(5):433-42. doi: 10.1016/0013-4694(89)90093-x. Electroencephalogr Clin Neurophysiol. 1989. PMID: 2479522 - [Biological diagnostic criteria in multiple sclerosis].
Dimitri D. Dimitri D. Rev Neurol (Paris). 2001 Sep;157(8-9 Pt 2):968-73. Rev Neurol (Paris). 2001. PMID: 11787362 Review. French. - Multiple sclerosis - etiology and diagnostic potential.
Kamińska J, Koper OM, Piechal K, Kemona H. Kamińska J, et al. Postepy Hig Med Dosw (Online). 2017 Jun 30;71(0):551-563. doi: 10.5604/01.3001.0010.3836. Postepy Hig Med Dosw (Online). 2017. PMID: 28665284 Review.
Cited by
- Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study.
Vidal-Jordana A, Rovira A, Calderon W, Arrambide G, Castilló J, Moncho D, Rahnama K, Collorone S, Toosy AT, Ciccarelli O, Papadopoulou A, Cerdá-Fuertes N, Lieb JM, Ruggieri S, Tortorella C, Gasperini C, Bisecco A, Capuano R, Gallo A, De Barros A, Salerno A, Auger C, Sastre-Garriga J, Tintore M, Montalban X. Vidal-Jordana A, et al. Neurology. 2024 Jan 9;102(1):e200805. doi: 10.1212/WNL.0000000000207805. Epub 2023 Dec 13. Neurology. 2024. PMID: 38165378 - Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
Butzkueven H, Ponsonby AL, Stein MS, Lucas RM, Mason D, Broadley S, Kilpatrick T, Lechner-Scott J, Barnett M, Carroll W, Mitchell P, Hardy TA, Macdonell R, McCombe P, Lee A, Kalincik T, van der Walt A, Lynch C, Abernethy D, Willoughby E, Barkhof F, MacManus D, Clarke M, Andrew J, Morahan J, Zhu C, Dear K, Taylor BV; PREVANZ Investigators. Butzkueven H, et al. Brain. 2024 Apr 4;147(4):1206-1215. doi: 10.1093/brain/awad409. Brain. 2024. PMID: 38085047 Free PMC article. Clinical Trial. - Neuroimaging Scoring Tools to Differentiate Inflammatory Central Nervous System Small-Vessel Vasculitis: A Need for Artificial Intelligence/Machine Learning?-A Scoping Review.
Damer A, Chaudry E, Eftekhari D, Benseler SM, Safi F, Aviv RI, Tyrrell PN. Damer A, et al. Tomography. 2023 Oct 2;9(5):1811-1828. doi: 10.3390/tomography9050144. Tomography. 2023. PMID: 37888736 Free PMC article. Review. - The Patient-Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis.
Foong YC, Merlo D, Gresle M, Zhu C, Buzzard K, Lechner-Scott J, Barnett M, Taylor B, Kalincik T, Kilpatrick T, Darby D, Dobay P, van Beek J, Hyde R, Butzkueven H, van der Walt A. Foong YC, et al. Eur J Neurol. 2024 Jan;31(1):e16046. doi: 10.1111/ene.16046. Epub 2023 Aug 24. Eur J Neurol. 2024. PMID: 37584176 Free PMC article. - Clinical spectrum and prognosis of pathologically confirmed atypical tumefactive demyelinating lesions.
Zhang Y, Zhang T, Zhang X, Yan X, Lei J, Liu R, Yang Y, Zhang C, Zhang J, Zhang Y, Yue W. Zhang Y, et al. Sci Rep. 2023 May 13;13(1):7773. doi: 10.1038/s41598-023-34420-4. Sci Rep. 2023. PMID: 37179394 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous